Global and Japan Bioactive Protein and Peptides Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and Japan Bioactive Protein and Peptides Market

This report focuses on global and Japan Bioactive Protein and Peptides market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Bioactive Protein and Peptides market size is estimated to be worth US$ 1,695.84 million in 2022 and is forecast to a readjusted size of US$ 2,533.48 million by 2028 with a CAGR of 6.92% during the review period. Fully considering the economic change by this health crisis, Plant Source accounting for 55.64% of the Bioactive Protein and Peptides global market in 2021, is projected to value US$ 1,480.85 million by 2028, growing at a revised 7.66% CAGR in the post-COVID-19 period. While Dietary Supplements was the leading segment, accounting for over 42.79% percent market share in 2021, and altered to an 7.55% CAGR throughout this forecast period.

In Japan the Bioactive Protein and Peptides market size is expected to grow from US$ 52.35 million in 2021 to US$ 87.17 million by 2028, at a CAGR of 7.75% during the forecast period.

Global Bioactive Protein and Peptides Scope and Market Size

Bioactive Protein and Peptides market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Bioactive Protein and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

For Japan market, this report focuses on the Bioactive Protein and Peptides market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in Japan.

Segment by Type

Plant Source

Animal Source

Segment by Application

Dietary Supplements

Functional Food

Personal Care

Animal Nutrition

Other

By Company

Gelita

Kerry Group

Vital Proteins

Rousselot

BRF Ingredients

Bunge Ltd

Ingredia Nutritional

Gelatines Weishardt

PanTheryx

Hubei Rui Biological Technology

Seagarden

Shandong Hengxin Biotech

Baotou Dongbao Bio-Tech

Wuhan Jiushengtang Biotech

Morinaga Milk

Collagile

Nuritas

SmartPEP

By Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

Korea

Australia

South Asia

India

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

GCC Countries

Turkey

South Africa

Egypt


1 Study Coverage
1.1 Bioactive Protein and Peptides Product Introduction
1.2 Global Bioactive Protein and Peptides Outlook, 2017 VS 2022 VS 2028
1.2.1 Global Bioactive Protein and Peptides Market Size for the Year 2017-2028
1.2.2 Japan Bioactive Protein and Peptides Market Size for the Year 2017-2028
1.3 Bioactive Protein and Peptides Market Size, Japan VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of Japan Bioactive Protein and Peptides in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Bioactive Protein and Peptides Market Size, Japan VS Global, 2017 VS 2022 VS 2028
1.4 Bioactive Protein and Peptides Market Dynamics
1.4.1 Bioactive Protein and Peptides Industry Trends
1.4.2 Bioactive Protein and Peptides Market Drivers
1.4.3 Bioactive Protein and Peptides Market Challenges
1.5 Study Objectives
1.6 Years Considered
2 Bioactive Protein and Peptides by Type
2.1 Bioactive Protein and Peptides Market Segment by Type
2.1.1 Plant Source
2.1.2 Animal Source
2.2 Global Bioactive Protein and Peptides Market Size by Type (2017, 2022 & 2028)
2.3 Global Bioactive Protein and Peptides Market Size by Type (2017-2028)
2.4 Japan Bioactive Protein and Peptides Market Size by Type (2017, 2022 & 2028)
2.5 Japan Bioactive Protein and Peptides Market Size by Type (2017-2028)
3 Bioactive Protein and Peptides by Application
3.1 Bioactive Protein and Peptides Market Segment by Application
3.1.1 Dietary Supplements
3.1.2 Functional Food
3.1.3 Personal Care
3.1.4 Animal Nutrition
3.2 Global Bioactive Protein and Peptides Market Size, by Application (2017, 2022 & 2028)
3.3 Global Bioactive Protein and Peptides Market Size by Application (2017-2028)
3.4 Japan Bioactive Protein and Peptides Market Size by Application (2017, 2022 & 2028)
3.5 Japan Bioactive Protein and Peptides Market Size by Application (2017-2028)
4 Global Bioactive Protein and Peptides Competitor Landscape by Company
4.1 Global Bioactive Protein and Peptides Market Size by Company
4.1.1 Top Global Bioactive Protein and Peptides Companies Ranked by Revenue (2021)
4.1.2 Global Bioactive Protein and Peptides Revenue by Player (2017-2022)
4.2 Global Bioactive Protein and Peptides Concentration Ratio (CR)
4.2.1 Bioactive Protein and Peptides Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Bioactive Protein and Peptides in 2021
4.2.3 Global Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Bioactive Protein and Peptides Headquarters, Product Type
4.3.1 Global Bioactive Protein and Peptides Headquarters and Area Served
4.3.2 Global Bioactive Protein and Peptides Companies Product Type
4.3.3 Date of International Companies Establishment
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 Japan Bioactive Protein and Peptides Market Size by Company
4.5.1 Top Bioactive Protein and Peptides Players in Japan, Ranked by Revenue (2021)
4.5.2 Japan Bioactive Protein and Peptides Revenue by Players (2020, 2021 & 2022)
5 Global Bioactive Protein and Peptides Market Size by Region
5.1 Global Bioactive Protein and Peptides Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Bioactive Protein and Peptides Market Size by Region (2017-2028)
5.2.1 Global Bioactive Protein and Peptides Market Size by Region: 2017-2022
5.2.2 Global Bioactive Protein and Peptides Market Size by Region: 2023-2028
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
6.1.2 North America Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Bioactive Protein and Peptides Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 Australia
6.2.7 Southeast Asia
6.2.8 India
6.3 Europe
6.3.1 Europe Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
6.3.2 Europe Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
6.4.2 Latin America Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Brazil
6.4.4 Mexico
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Bioactive Protein and Peptides Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Bioactive Protein and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 GCC Countries
6.5.4 Turkey
6.5.5 Egypt
6.5.6 South Africa
7 Key Players Profiles
7.1 Gelita
7.1.1 Gelita Company Details
7.1.2 Gelita Business Overview
7.1.3 Gelita Bioactive Protein and Peptides Introduction
7.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.2 Kerry Group
7.2.1 Kerry Group Company Details
7.2.2 Kerry Group Business Overview
7.2.3 Kerry Group Bioactive Protein and Peptides Introduction
7.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.3 Vital Proteins
7.3.1 Vital Proteins Company Details
7.3.2 Vital Proteins Business Overview
7.3.3 Vital Proteins Bioactive Protein and Peptides Introduction
7.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.4 Rousselot
7.4.1 Rousselot Company Details
7.4.2 Rousselot Business Overview
7.4.3 Rousselot Bioactive Protein and Peptides Introduction
7.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.5 BRF Ingredients
7.5.1 BRF Ingredients Company Details
7.5.2 BRF Ingredients Business Overview
7.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction
7.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.6 Bunge Ltd
7.6.1 Bunge Ltd Company Details
7.6.2 Bunge Ltd Business Overview
7.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction
7.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.7 Ingredia Nutritional
7.7.1 Ingredia Nutritional Company Details
7.7.2 Ingredia Nutritional Business Overview
7.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction
7.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.8 Gelatines Weishardt
7.8.1 Gelatines Weishardt Company Details
7.8.2 Gelatines Weishardt Business Overview
7.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction
7.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.9 PanTheryx
7.9.1 PanTheryx Company Details
7.9.2 PanTheryx Business Overview
7.9.3 PanTheryx Bioactive Protein and Peptides Introduction
7.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.10 Hubei Reborn Biotech
7.10.1 Hubei Reborn Biotech Company Details
7.10.2 Hubei Reborn Biotech Business Overview
7.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction
7.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.11 Seagarden
7.11.1 Seagarden Company Details
7.11.2 Seagarden Business Overview
7.11.3 Seagarden Bioactive Protein and Peptides Introduction
7.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.12 Shandong Hengxin Biotech
7.12.1 Shandong Hengxin Biotech Company Details
7.12.2 Shandong Hengxin Biotech Business Overview
7.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction
7.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.13 Baotou Dongbao Bio-Tech
7.13.1 Baotou Dongbao Bio-Tech Company Details
7.13.2 Baotou Dongbao Bio-Tech Business Overview
7.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction
7.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.14 Wuhan Jiushengtang Biotech
7.14.1 Wuhan Jiushengtang Biotech Company Details
7.14.2 Wuhan Jiushengtang Biotech Business Overview
7.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction
7.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.15 Morinaga Milk
7.15.1 Morinaga Milk Company Details
7.15.2 Morinaga Milk Business Overview
7.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction
7.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.16 Collagile
7.16.1 Collagile Company Details
7.16.2 Collagile Business Overview
7.16.3 Collagile Bioactive Protein and Peptides Introduction
7.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.17 Nuritas
7.17.1 Nuritas Company Details
7.17.2 Nuritas Business Overview
7.17.3 Nuritas Bioactive Protein and Peptides Introduction
7.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2017-2022)
7.17.5 Nuritas Recent Development
7.18 SmartPEP
7.18.1 SmartPEP Company Details
7.18.2 SmartPEP Business Overview
7.18.3 SmartPEP Bioactive Protein and Peptides Introduction
7.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2017-2022)
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Disclaimer
9.3 Author Details
List of Tables
Table 1. Bioactive Protein and Peptides Market Size, Japan VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Bioactive Protein and Peptides Market Trends
Table 3. Bioactive Protein and Peptides Market Drivers
Table 4. Bioactive Protein and Peptides Market Challenges
Table 5. Global Bioactive Protein and Peptides Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 6. Japan Bioactive Protein and Peptides Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. Global Bioactive Protein and Peptides Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Japan Bioactive Protein and Peptides Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. Top Bioactive Protein and Peptides Companies in Global Market, Ranking by Revenue (2021)
Table 10. Global Bioactive Protein and Peptides Revenue by Player, (US$ Million), 2017-2022
Table 11. Global Bioactive Protein and Peptides Revenue Share by Player, 2017-2022
Table 12. Global Bioactive Protein and Peptides Companies Market Concentration Ratio (CR5)
Table 13. Global Bioactive Protein and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2021)
Table 14. Top Players of Bioactive Protein and Peptides in Global Market, Headquarters and Area Served
Table 15. Global Bioactive Protein and Peptides Companies Product Type
Table 16. Date of International Companies Establishment
Table 17. Companies Mergers & Acquisitions, Expansion Plans
Table 18. Top Bioactive Protein and Peptides Players in Japan Market, Ranking by Revenue (2021)
Table 19. Japan Bioactive Protein and Peptides Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 20. Japan Bioactive Protein and Peptides Revenue Share by Players, 2020, 2021 & 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings